home All News open_in_new Full Article

Los aranceles de Trump a los medicamentos dan nuevos frutos: GSK y Lilly invertirán 29.532 millones en EEUU

Ambas compañías han anunciado nuevos planes en Estados Unidos. Más información: Reino Unido, víctima de las amenazas de Trump: AstraZeneca y MSD paralizan sus inversiones en el país


today 5 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 3479215944
Add Watch Country

arrow_drop_down